AstraZeneca Pharma India Limited (ASTRAZENECA PHARMA IND LT) Aktie
ASTRAZEN.NS
ASTRAZENECA PHARMA IND LT
Market Cap
$218,225,000,448
Über AstraZeneca Pharma India Limited (ASTRAZENECA PHARMA IND LT) Aktie
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Unternehmensinformationen
560045 Bengaluru, India
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.